US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.100
  • -0.100-4.55%
Close Apr 26 16:00 ET
24.23MMarket Cap-7984P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics Earnings Date

Currency: SGD

Period

FY2023 Annual Report

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.39

-36.26%
Analyst Rating

No Data

CytoMed Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 130.000K--
--2024/Q1-- / 130.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 130.000K--
--2024/Q1-- / 130.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--

CytoMed Therapeutics Earnings Reports

  • CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Apr 25 15:36 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 24 16:19 ET

  • CytoMed Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 22 17:27 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 17, 2023 09:33 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg